Alnylam Pharmaceuticals
| Use attributes for filter ! | |
| Web site | www.alnylam.com |
|---|---|
| Number of employees | > 500 (2017) |
| Ceo | John Maraganore |
| Headquarters | Cambridge |
| Massachusetts | |
| United States | |
| Founders | Phillip Allen Sharp |
| Subsidiaries | Regulus Therapeutics Inc. |
| Sirna Therapeutics | |
| Date of Reg. | |
| Date of Upd. | |
| ID | 672673 |
About Alnylam Pharmaceuticals
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of RNA interference therapeutics for genetically defined diseases. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts.
